174 results
Page 3 of 9
8-K
EX-99.2
9u2tcljoxv
14 Jan 15
Regulation FD Disclosure
12:00am
8-K
EX-99.1
a6pt w9leqr7
12 Jul 06
Departure of Directors or Principal Officers
12:00am
8-K
EX-99.1
1i1 cd9u3gj9t
30 Sep 15
Transgenomic Signs Binding Term Sheet to Divest Genetic Assays & Platforms Business Unit
12:00am
8-K
EX-99.1
o34p1z4zo0xiw752i6pb
18 Apr 07
Departure of Directors or Principal Officers
12:00am
8-K
EX-99.1
6i26il
30 Sep 13
Transgenomic Announces Executive Changes
12:00am
8-K
EX-99.1
o2dw7v5gme b18
17 Sep 12
Departure of Directors or Certain Officers
12:00am
8-K
EX-99.1
hymrpt6r47p6900u
13 Mar 13
Transgenomic Secures $8.0 Million Credit Facility
12:00am
8-K
EX-99.1
5u8v7cj9s
5 Mar 07
Departure of Directors or Principal Officers
12:00am
8-K
EX-99.1
tk6xksa4x2pgz5 an
25 Jan 13
Transgenomic Announces $8.3 Million Private Placement Financing
12:00am
8-K
EX-99.1
jqup5a
4 Dec 19
Precipio Announces the Resignation of Samuel Riccitelli and the Introduction of Richard Sandberg to its Board of Directors
4:01pm
8-K
EX-99.1
q0x 5kmx2909ygly4p
27 Sep 12
Transgenomic Completes Acquisition of ScoliScore™ Prognostic Scoliosis Test
12:00am
8-K
61kmcyuh81 oh
19 Mar 14
Dr. Michael A. Luther Joins Transgenomic’s Board of Directors
12:00am
8-K
EX-99.1
da0o72m7
31 May 01
Current report
12:00am
8-K
EX-99.1
m8hd p1bccfh0u0h
2 Jan 24
Precipio Announces Christina Valauri joins the Board of Directors
5:01pm
8-K
EX-99.1
i4fsicxu4
25 Feb 22
Precipio Releases Year-End 2021 Preliminary Unaudited Results and Outlook for 2022
6:51pm
8-K
EX-99.1
aqiejdbk rursi
12 May 04
Other events
12:00am
8-K
EX-99.1
huxfw4p92j
28 Aug 12
Transgenomic Acquires ScoliScore™ Adolescent Idiopathic Scoliosis Prognostic Test from Axial Biotech
12:00am
8-K
EX-99.1
wb7v8054
13 May 09
Transgenomic, Inc. Reports First Quarter 2009 Results
12:00am
8-K
EX-99.1
2i724 05p
8 May 13
Transgenomic Reports First Quarter 2013 Financial Results
12:00am
8-K
EX-99
lf7igs3kmn4 58m
7 May 08
Results of Operations and Financial Condition
12:00am